DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award

Rhea-AI Filing Summary

DaVita Inc. (DVA) reported an insider equity award to board member Phyllis R. Yale. On 2026-08-15 she received a grant of 278 shares of Common Stock at a stated price of $0.00 per share, classified as a grant/award acquisition. Following this award, she directly holds 9,803 DaVita common shares. No sales or derivative transactions were reported in this filing.

Insider Trade Summary

Net Buyer: 278 shares

Net Buy 1 txn

Insider YALE PHYLLIS R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	278	$0.00	$0.00

Holdings After Transaction: Common Stock — 9,803 shares (Direct)

Key Figures

Shares granted: 278 shares Grant price per share: $0.00 per share Shares owned after transaction: 9,803 shares +1 more

4 metrics

Shares granted 278 shares Non-derivative grant/award of DaVita common stock on 2026-08-15

Grant price per share $0.00 per share Stated transaction price for the 278-share common stock award

Shares owned after transaction 9,803 shares Total DaVita common shares directly held by Phyllis R. Yale following the grant

Acquire transactions in filing 1 transaction Form 4 transaction summary shows one acquire-type transaction and no sales

Key Terms

grant/award acquisition, non-derivative, Form 4

3 terms

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

non-derivative financial

""transaction_type": "non-derivative""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transaction did DaVita (DVA) disclose for Phyllis R. Yale?

DaVita disclosed that director Phyllis R. Yale received a grant of 278 shares of DaVita common stock on 2026-08-15 as a non-derivative, compensation-related acquisition, with no corresponding sale reported.

How many DaVita (DVA) shares does Phyllis R. Yale own after this Form 4 transaction?

After the reported grant, Phyllis R. Yale directly owns 9,803 shares of DaVita common stock. This total reflects the addition of 278 granted shares and represents her reported direct holdings following the transaction.

Was the DaVita (DVA) insider transaction a purchase or a grant?

The DaVita transaction was reported as a grant/award acquisition, not an open-market purchase. Phyllis R. Yale received 278 shares of common stock at a stated price of $0.00 per share, typical of equity compensation awards.

Did Phyllis R. Yale sell any DaVita (DVA) shares in this Form 4 filing?

No sales were reported. The Form 4 shows only an acquisition of 278 shares of DaVita common stock by grant/award, with no disposition, sale, or derivative exercise transactions included in this filing.

Is the DaVita (DVA) insider grant to Phyllis R. Yale under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed. It reports one grant/award acquisition of 278 shares to Phyllis R. Yale, with no disclosure that the transaction was executed pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 06:11 PM Accepted by SEC EDGAR 08/18/2026 - 06:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

YALE PHYLLIS R

(Last) (First) (Middle)

C/O DAVITA INC

2000 16TH STREET

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2026		A		278	A	$0	9,803	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stephanie N. Berberich, Attorney-in-Fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)